Excipient Exception : A Complication of Infliximab and Vedolizumab Infusions for Ulcerative Colitis
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:68 |
---|---|
Enthalten in: |
Digestive diseases and sciences - 68(2023), 5 vom: 16. Mai, Seite 1709-1713 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Dalal, Rahul S [VerfasserIn] |
---|
Links: |
---|
Themen: |
9RV78Q2002 |
---|
Anmerkungen: |
Date Completed 28.04.2023 Date Revised 01.05.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s10620-023-07866-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM35434725X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM35434725X | ||
003 | DE-627 | ||
005 | 20231226062025.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10620-023-07866-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1181.xml |
035 | |a (DE-627)NLM35434725X | ||
035 | |a (NLM)36929242 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Dalal, Rahul S |e verfasserin |4 aut | |
245 | 1 | 0 | |a Excipient Exception |b A Complication of Infliximab and Vedolizumab Infusions for Ulcerative Colitis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.04.2023 | ||
500 | |a Date Revised 01.05.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Eosinophils | |
650 | 4 | |a Gastritis | |
650 | 4 | |a Infliximab | |
650 | 4 | |a Infusion | |
650 | 4 | |a Ulcerative colitis | |
650 | 4 | |a Vedolizumab | |
650 | 7 | |a Infliximab |2 NLM | |
650 | 7 | |a B72HH48FLU |2 NLM | |
650 | 7 | |a vedolizumab |2 NLM | |
650 | 7 | |a 9RV78Q2002 |2 NLM | |
650 | 7 | |a Excipients |2 NLM | |
650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
650 | 7 | |a Gastrointestinal Agents |2 NLM | |
700 | 1 | |a Goksel, Behiye |e verfasserin |4 aut | |
700 | 1 | |a Hamilton, Matthew J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Digestive diseases and sciences |d 1989 |g 68(2023), 5 vom: 16. Mai, Seite 1709-1713 |w (DE-627)NLM000356492 |x 1573-2568 |7 nnns |
773 | 1 | 8 | |g volume:68 |g year:2023 |g number:5 |g day:16 |g month:05 |g pages:1709-1713 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10620-023-07866-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 68 |j 2023 |e 5 |b 16 |c 05 |h 1709-1713 |